A citation-based method for searching scientific literature

Raymond Y Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, Jaishri Blakeley, Ian Dunn, Evanthia Galanis, Matthias Preusser, Michael McDermott, Leland Rogers, Jeffrey Raizer, David Schiff, Riccardo Soffietti, Jörg-Christian Tonn, Michael Vogelbaum, Damien Weber, David A Reardon, Patrick Y Wen. Neuro Oncol 2019
Times Cited: 53







List of co-cited articles
309 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
368
43

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
290
26

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
121
24

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
322
22

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
22

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
474
20

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.
Abdurrahman I Islim, Midhun Mohan, Richard D C Moon, Nisaharan Srikandarajah, Samantha J Mills, Andrew R Brodbelt, Michael D Jenkinson. J Neurooncol 2019
57
20


Radiosurgery as definitive management of intracranial meningiomas.
Douglas Kondziolka, David Mathieu, L Dade Lunsford, Juan J Martin, Ricky Madhok, Ajay Niranjan, John C Flickinger. Neurosurgery 2008
258
18

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
185
16

The natural history of intracranial meningiomas.
Soichi Oya, Seon-Hwan Kim, Burak Sade, Joung H Lee. J Neurosurg 2011
137
16

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
580
16

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
Emil Lou, Ashley L Sumrall, Scott Turner, Katherine B Peters, Annick Desjardins, James J Vredenburgh, Roger E McLendon, James E Herndon, Frances McSherry, Julie Norfleet,[...]. J Neurooncol 2012
112
15

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
142
15

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Kent C Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B Weir, Gregg C Shepard, Jeffrey T Williams, Mythili Shastry, Howard A Burris, John D Hainsworth. J Neurooncol 2016
49
16

Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
109
15

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette,[...]. J Neurosurg 2018
103
15

Treatment decision making based on the published natural history and growth rate of small meningiomas.
Michael E Sughrue, Martin J Rutkowski, Derick Aranda, Igor J Barani, Michael W McDermott, Andrew T Parsa. J Neurosurg 2010
96
15

A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas.
Abdurrahman I Islim, Ruwanthi Kolamunnage-Dona, Midhun Mohan, Richard D C Moon, Anna Crofton, Brian J Haylock, Nitika Rathi, Andrew R Brodbelt, Samantha J Mills, Michael D Jenkinson. Neuro Oncol 2020
22
31

Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas.
Tetsuo Hashiba, Naoya Hashimoto, Shuichi Izumoto, Tsuyoshi Suzuki, Naoki Kagawa, Motohiko Maruno, Amami Kato, Toshiki Yoshimine. J Neurosurg 2009
91
13

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
839
13

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Thomas Graillon, Marc Sanson, Chantal Campello, Ahmed Idbaih, Matthieu Peyre, Hadrien Peyrière, Noémie Basset, Didier Autran, Catherine Roche, Michel Kalamarides,[...]. Clin Cancer Res 2020
38
18

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
101
13

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
373
11

Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
Marta Simó, Andreas A Argyriou, Miquel Macià, Gerard Plans, Carles Majós, Noemi Vidal, Miguel Gil, Jordi Bruna. Cancer Chemother Pharmacol 2014
38
15

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Marc C Chamberlain, Michael J Glantz, Camilo E Fadul. Neurology 2007
119
11

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Andrew D Norden, Keith L Ligon, Samantha N Hammond, Alona Muzikansky, David A Reardon, Thomas J Kaley, Tracy T Batchelor, Scott R Plotkin, Jeffrey J Raizer, Eric T Wong,[...]. Neurology 2015
50
12

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
166
11

A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas.
Eun Jung Lee, Jeong Hoon Kim, Eun Suk Park, Young-Hoon Kim, Jae Koo Lee, Seok Ho Hong, Young Hyun Cho, Chang Jin Kim. J Neurosurg 2017
30
20

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
157
11

An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study.
Jason Sheehan, Stylianos Pikis, Abdurrahman I Islim, Ching-Jen Chen, Adomas Bunevicius, Selcuk Peker, Yavuz Samanci, Ahmed M Nabeel, Wael A Reda, Sameh R Tawadros,[...]. Neuro Oncol 2022
9
66

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, Andrew D Norden, Timothy F Cloughesy, Lauren E Abrey, Howard A Fine, Susan M Chang, H Ian Robins, Karen Fink,[...]. Neuro Oncol 2009
89
9

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
Damien C Weber, Carmen Ares, Salvador Villa, Saskia M Peerdeman, Laurette Renard, Brigitta G Baumert, Anna Lucas, Theo Veninga, Alessia Pica, Sarah Jefferies,[...]. Radiother Oncol 2018
64
9

Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
Walter Rachinger, Veit M Stoecklein, Nicole A Terpolilli, Alexander R Haug, Lorenz Ertl, Julia Pöschl, Ulrich Schüller, Christian Schichor, Niklas Thon, Jörg-Christian Tonn. J Nucl Med 2015
71
9

Stereotactic radiosurgery--an organized neurosurgery-sanctioned definition.
Gene H Barnett, Mark E Linskey, John R Adler, Jeffrey W Cozzens, William A Friedman, M Peter Heilbrun, L Dade Lunsford, Michael Schulder, Andrew E Sloan. J Neurosurg 2007
108
9

The natural history of incidental meningiomas.
Makoto Nakamura, Florian Roser, Julia Michel, Cornelius Jacobs, Madjid Samii. Neurosurgery 2003
230
9

Meningiomas.
Ian R Whittle, Colin Smith, Parthiban Navoo, Donald Collie. Lancet 2004
387
9

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
C Leland Rogers, Minhee Won, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, Shannon E Fogh, Emad Youssef,[...]. Int J Radiat Oncol Biol Phys 2020
40
12

Relationship between tumor location, size, and WHO grade in meningioma.
Stephen T Magill, Jacob S Young, Ricky Chae, Manish K Aghi, Philip V Theodosopoulos, Michael W McDermott. Neurosurg Focus 2018
47
10

Incidence and clinical features of asymptomatic meningiomas.
J Kuratsu, M Kochi, Y Ushio. J Neurosurg 2000
137
9


DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, Jetan H Badhiwala, Sheila Mansouri, Shirin Karimi, Olli Saarela, Laila Poisson, Irina Gepfner-Tuma, Jens Schittenhelm,[...]. Neuro Oncol 2019
76
9

Outcomes from treatment of asymptomatic skull base meningioma with stereotactic radiosurgery.
Stylianos Pikis, Adomas Bunevicius, Jason Sheehan. Acta Neurochir (Wien) 2021
8
62

Radiotherapy and radiosurgery for benign skull base meningiomas.
Giuseppe Minniti, Maurizio Amichetti, Riccardo Maurizi Enrici. Radiat Oncol 2009
92
7

Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Sara Arena, Federica Barbieri, Stefano Thellung, Paolo Pirani, Alessandro Corsaro, Valentina Villa, Patrizia Dadati, Alessandra Dorcaratto, Gabriella Lapertosa, Jean-Louis Ravetti,[...]. J Neurooncol 2004
74
7

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Yongli Ji, Cathryn Rankin, Steven Grunberg, Andy E Sherrod, Jamshid Ahmadi, Jeannette J Townsend, Lynn G Feun, Ruth K Fredericks, Christy A Russell, Fairooz F Kabbinavar,[...]. J Clin Oncol 2015
64
7

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Adriana Olar, Khalida M Wani, Charmaine D Wilson, Gelareh Zadeh, Franco DeMonte, David T W Jones, Stefan M Pfister, Erik P Sulman, Kenneth D Aldape. Acta Neuropathol 2017
69
7

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
121
7

PET imaging in patients with meningioma-report of the RANO/PET Group.
Norbert Galldiks, Nathalie L Albert, Michael Sommerauer, Anca L Grosu, Ute Ganswindt, Ian Law, Matthias Preusser, Emilie Le Rhun, Michael A Vogelbaum, Gelareh Zadeh,[...]. Neuro Oncol 2017
80
7

Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up.
Faruk Ildan, Tahsin Erman, A Iskender Göçer, Metin Tuna, Hüseyin Bağdatoğlu, Erdal Cetinalp, Refik Burgut. Skull Base 2007
81
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.